Cargando…

Characterization of amino acid residues of T-cell receptors interacting with HLA-A*02-restricted antigen peptides

BACKGROUND: The present study aimed to explore residues’ properties interacting with HLA-A*02-restricted peptides on T-cell receptors (TCRs) and their effects on bond types of interaction and binding free energy. METHODS: We searched the crystal structures of HLA-A*02-restricted peptide-TCR complexe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ying, Huang, Changxin, Su, Meng, Ge, Zuanmin, Gao, Lanlan, Shi, Yanfei, Wang, Xuechun, Chen, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039679/ https://www.ncbi.nlm.nih.gov/pubmed/33850892 http://dx.doi.org/10.21037/atm-21-835

Ejemplares similares

Related parameters of affinity and stability prediction of HLA-A*2402 restricted antigen peptides based on molecular docking
por: Huang, Changxin, et al.
Publicado: (2021)

Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8(+) T cells
por: Ma, Yan, et al.
Publicado: (2020)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

Structure-Based Modeling of SARS-CoV-2 Peptide/HLA-A02 Antigens
por: Nerli, Santrupti, et al.
Publicado: (2020)

Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
por: El Bissati, Kamal, et al.
Publicado: (2020)

Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8(+) T cells
por: Schlott, Fabian, et al.
Publicado: (2018)

The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection
por: Abels, Wiebke C., et al.
Publicado: (2018)

Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA
Publicado: (1988)

Releasing the concept of HLA‐allele specific peptide anchors in viral infections: A non‐canonical naturally presented human cytomegalovirus‐derived HLA‐A*24:02 restricted peptide drives exquisite immunogenicity
por: Pump, Wiebke C., et al.
Publicado: (2019)

T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell
por: Liu, Sai, et al.
Publicado: (2019)

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2020)

Clonal distribution of HLA-restricted antigen-reactive T cells in man
Publicado: (1979)

Definition and characterization of novel HLA-*A02-restricted CD8(+) T cell epitopes derived from JCV polyomavirus with clinical relevance
por: Mani, Jiju, et al.
Publicado: (2016)

The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B*07:02
por: Mukherjee, Soumya, et al.
Publicado: (2021)

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021)

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2021)

Predicting HLA Class I Non-Permissive Amino Acid Residues Substitutions
por: Binkowski, T. Andrew, et al.
Publicado: (2012)

Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma
por: Wang, Stacie S., et al.
Publicado: (2023)

Immunodominant Tuberculosis CD8 Antigens Preferentially Restricted by HLA-B
por: Lewinsohn, Deborah A, et al.
Publicado: (2007)

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Hwang, Michael S., et al.
Publicado: (2021)

The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
por: Szeto, Christopher, et al.
Publicado: (2021)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope
por: MacLachlan, Bruce J., et al.
Publicado: (2019)

Natural Antigenic Peptides from Squamous Cell Carcinoma Recognized by Autologous HLA‐DR8–restricted CD4(+) T Cells
por: Kondo, Hiroaki, et al.
Publicado: (2002)

Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides
por: Chatzileontiadou, Demetra S.M., et al.
Publicado: (2021)

Human Leukocyte Antigen (HLA) and Gulf War Illness (GWI): HLA-DRB1*13:02 Spares Subcortical Atrophy in Gulf War Veterans
por: James, Lisa M., et al.
Publicado: (2017)

A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients
por: Gallou, Catherine, et al.
Publicado: (2016)

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
Publicado: (1994)

HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint
por: Hò, Gia-Gia T., et al.
Publicado: (2019)

Characterization of the novel HLA‐DRB3*02:179N allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

Characterization of the novel HLA‐DQA1*02:01:14 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

Characterization of the novel HLA‐DPA1*02:01:21 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells
Publicado: (1990)

Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies
por: Matsushita, Maiko, et al.
Publicado: (2016)

Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope
por: Nguyen, Thi HO, et al.
Publicado: (2017)

HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen
por: Mock, Jee-Young, et al.
Publicado: (2022)

Deduced probable human leukocyte antigen haplotypes associated with HLA-A*11:256Q and HLA-A*02:621 identified by case analyses of Taiwanese individuals
por: Yang, Kuo-Liang, et al.
Publicado: (2017)

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds
por: Buchner, Amanda, et al.
Publicado: (2021)

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides
por: Pedersen, Sara Ram, et al.
Publicado: (2016)

CD8(+) T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
por: Hensen, Luca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vgq6k47s9f1iee4s09m7fp59ep